JNJ

167.29

-0.43%↓

NVS

116.69

-0.32%↓

ABT

128.65

+0.56%↑

TMO

477.27

-1.09%↓

ISRG

500.18

+0.72%↑

JNJ

167.29

-0.43%↓

NVS

116.69

-0.32%↓

ABT

128.65

+0.56%↑

TMO

477.27

-1.09%↓

ISRG

500.18

+0.72%↑

JNJ

167.29

-0.43%↓

NVS

116.69

-0.32%↓

ABT

128.65

+0.56%↑

TMO

477.27

-1.09%↓

ISRG

500.18

+0.72%↑

JNJ

167.29

-0.43%↓

NVS

116.69

-0.32%↓

ABT

128.65

+0.56%↑

TMO

477.27

-1.09%↓

ISRG

500.18

+0.72%↑

JNJ

167.29

-0.43%↓

NVS

116.69

-0.32%↓

ABT

128.65

+0.56%↑

TMO

477.27

-1.09%↓

ISRG

500.18

+0.72%↑

Search

Edwards Lifesciences Corp

Cerrado

SectorSanidad

81.22 1.21

Resumen

Variación precio

24h

Actual

Mínimo

80

Máximo

81.86

Métricas clave

By Trading Economics

Ingresos

-28M

358M

Ventas

120M

1.5B

P/B

Media del Sector

32.841

40.048

BPA

0.64

Margen de beneficios

25.342

Empleados

15,800

EBITDA

-34M

400M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+9.93% upside

Dividendos

By Dow Jones

Próximas Ganancias

23 oct 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

1.1B

46B

Apertura anterior

80.01

Cierre anterior

81.22

Noticias sobre sentimiento de mercado

By Acuity

38%

62%

128 / 375 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Weak Bearish Evidence

Edwards Lifesciences Corp Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

25 oct 2024, 09:10 UTC

Ganancias

These Stocks Are Moving the Most Today: Tesla, Capri, Western Digital, Spirit Airlines, Deckers, Coursera, and More -- Barrons.com

25 oct 2024, 08:35 UTC

Ganancias

These Stocks Are Moving the Most Today: Tesla, Capri, Western Digital, Spirit Airlines, Deckers, Coursera, and More -- Barrons.com

3 sept 2024, 20:38 UTC

Adquisiciones, fusiones, absorciones

Edwards Lifesciences: After Recent Accelerated Repurchase Agreement and August Buybacks Via 10b5-1 Agreement and Open Market Repurchases, Company Has $1.4B in Remaining Authorization

3 sept 2024, 20:37 UTC

Adquisiciones, fusiones, absorciones

Edwards Lifesciences Completes Sale of Critical Care Group to Becton Dickinson for $4.2B

3 sept 2024, 20:36 UTC

Adquisiciones, fusiones, absorciones

Edwards Lifesciences Authorizes $1.5B of Additional Share Repurchases

Comparación entre iguales

Cambio de precio

Edwards Lifesciences Corp previsión

Precio Objetivo

By TipRanks

9.93% repunte

Estimación a 12 Meses

Media 88.46 USD  9.93%

Máximo 101 USD

Mínimo 79 USD

De acuerdo con 26 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Edwards Lifesciences Corp Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

26 ratings

15

Comprar

11

Mantener

0

Vender

Puntuación técnica

By Trading Central

74.52 / 75.54Soporte y Resistencia

Corto Plazo

Weak Bearish Evidence

Medio plazo

Strong Bullish Evidence

Largo Plazo

Strong Bullish Evidence

Sentimiento

By Acuity

128 / 375 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Edwards Lifesciences Corp

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.